Dearth of smoking-induced mutations in oncogene-driven non-small-cell lung cancer despite smoking exposure
Huang, C.-Y.; Jiang, N.; Shen, M.; Lai, G.; Tan, A. C.; Jain, A.; Saw, S. P.; Ang, M.-K.; Ng, Q. S.; Lim, D. W.-T.; Kanesvaran, R.; Tan, E.-H.; Tan, W. L.; Ong, B.-H.; Chua, K. L.; Anantham, D.; Takano, A.; Lim, T. K. H.; Tam, W. L.; Sim, N. L.; Sanderup, A. J.; Tan, D. S. W.; Rozen, S. G.
Show abstract
Non-small cell lung cancers (NSCLCs) in non-smokers are mostly driven by mutations in the oncogenes EGFR, ERBB2, and MET, and fusions involving ALK and RET. We term these "non-smoking-related oncogenes" (NSROs). In addition to occurring in non-smokers, NSRO-driven tumors also occur in smokers, and the clonal architecture and genomic landscape of these tumors remain unknown. We investigated genomic and transcriptomic alterations in 173 tumor sectors from 48 patients with NSRO-driven or typical-smoking NSCLCs. NSRO-driven NSCLCs in smokers and non-smokers have similar genomic landscapes. Surprisingly, even in patients with prominent smoking histories, the mutational signature caused by tobacco smoking was essentially absent in NSRO-driven NSCLCs. However, NSRO-driven NSCLCs in smokers had higher transcriptomic activities related to regulation of the cell cycle, suggesting that smoking still affects tumor phenotype independently of genomic alterations. Statement of significanceThis study highlights the lack of genomic scars caused by smoking in NSCLCs driven by non-smoking-related oncogenes regardless of smoking history. The impact of smoking on these tumors is mainly non-genomic. The transcriptomic features of NSCLCs associated with smoking may help in the development of therapeutic approaches.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Multidimensional Characterization of Soft-Tissue Sarcomas with FUS-TFCP2 or EWSR1-TFCP2 Fusions 94%
- Copy number losses of oncogenes and gains of tumor suppressor genes generate common driver events of human cancer 94%
- Cross-Cancer Evaluation of Polygenic Risk Scores for 17 Cancer Types in Two Large Cohorts 94%
Similar papers in this journal
- Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression and drug response 95%
- A Genomically and Clinically Annotated Patient Derived Xenograft (PDX) Resource for Preclinical Research in Non-Small Cell Lung Cancer 95%
- Pan-cancer Drivers are Recurrent Transcriptional Regulatory Heterogeneities in Early-stage Luminal Breast Cancer 94%
Similar papers in this journal
- Increased inflammatory signature in myeloid cells of non-small cell lung cancer patients with high clonal hematopoiesis burden 95%
- Pan-cancer association of DNA repair deficiencies with whole-genome mutational patterns 95%
- Transcriptional pattern enriched for synaptic signaling is associated with shorter survival of patients with high-grade serous ovarian cancer 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.